title: Re-examining Nelson's syndrome.
abstract: OBJECTIVE
  Nelson's syndrome is a rare complication that can occur during the course of management of Cushing's disease. This article summarizes the recent literature on the diagnosis, monitoring and treatment of this potentially life-threatening outcome.
  
  
  RESULTS
  Nelson's syndrome, with rising adrenocorticotropin hormone levels and corticotroph tumor progression on diagnostic imaging, can develop following treatment of refractory Cushing's disease with total bilateral adrenalectomy with/without radiotherapy. However, data showing that radiotherapy prevents Nelson's syndrome is inconsistent. In addition to the treatment of Nelson's syndrome with neurosurgery with/without adjuvant radiotherapy, selective somatostatin analogs and dopamine agonists, as well as other novel agents, have been used with increasing frequency in treating cases of Nelson's syndrome with limited benefit. The risk-benefit profile of each of these therapies is still not completely understood.
  
  
  CONCLUSIONS
  Consensus guidelines on the evaluation and management of Nelson's syndrome are lacking. This article highlights areas in the surveillance of Cushing's disease patients, and diagnostic criteria and treatment regimens for Nelson's syndrome that require further research and review by experts in the field.
authors.affiliation: Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine, Boston, Massachusetts, USA.
authors.forename: Nadine E
authors.initials: NE
authors.lastname: Palermo
authors.forename: Sonia
authors.initials: S
authors.lastname: Ananthakrishnan
mesh_terms: D006801:Humans; D009347:Nelson Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy